Long-term Clinical Study of CN128 in Thalassemia Patients
Clinical trial NCT04614779 · COMPLETED
Trial details
- NCT number
- NCT04614779
- Sponsor
- Hangzhou Zede Pharma-Tech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2022-08-18
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.